SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation that cannabis rescheduling may be imminent, with some anticipating a resulting sector-wide surge. The community is actively discussing the potential impact of a presidential executive order on tax relief and banking access. Some investors are optimistic about a short squeeze, while others remain cautious due to the company's history.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending due to the upcoming launch of BlueBird 6, marking a significant step towards a launch cadence of approximately every 45 days in 2026; this represents a shift from concept to operational deployment. The community is buzzing about the potential for a Starlink competitor and the company's long-term prospects, with some highlighting the high short interest and potential for a squeeze.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU is trending due to its active community and ongoing initiatives, particularly the upcoming availability of Kendu Spice on Amazon. The community is actively discussing the project's strong IRL presence and the numerous businesses being built around the KENDU brand. Many see it as a long-term play with a dedicated and growing community.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

Aurora Cannabis is trending amidst reports that Trump may consider rescheduling marijuana, potentially affecting taxation and medical access. The community is discussing the potential impact of this policy change and whether it will be a "sell the news" event. Scanners continue to light up as cannabis tickers show increased interest in response to the news.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to speculation of a potential short squeeze, driven by its low float and recent AI deal. Community members are actively discussing key breakout levels and anticipating a significant price surge. The stock is drawing comparisons to other low-float runners, fueling excitement around potential for substantial gains.

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

BridgeBio Pharma Inc

BBIO is trending due to analyst upgrades and positive sentiment around the launch of Attruby, with the community actively discussing its potential to outperform competitors and the impact of upcoming Phase 3 readouts. Community members are weighing its growth potential in the context of a potentially undervalued biotech, while also considering the potential for acquisition by a major pharmaceutical company. Actionable trade alerts highlight possible entry and exit points based on technical analysis.

Gunz

Gunz ($GUN) is trending amid community excitement about potential breakouts and large whale buys, with some eyeing a return to all-time highs. The token is also getting attention due to its association with the Off The Grid (OTG) web3 game on the Avalanche network ($AVAX), leading to discussions about its tokenomics and potential for quick gains.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power ($SMR) is trending due to discussions around its potential role in powering AI data centers and a recent agreement with the Tennessee Valley Authority, though concerns persist around its financial performance and Fluor's stake monetization. The community is weighing the company's regulatory advantages and the increasing need for SMR technology against factors like potential share dilution and competition in the sector. Recent analyst target price reductions and overall nuclear sector bearishness may also be contributing to the conversation.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending due to positive reactions to its AI and autonomy day, with discussions focusing on the potential of its new in-house AI chip and self-driving capabilities. The community is weighing the company's advancements against competitors like Tesla and speculating on a possible short squeeze. Some investors are concerned about cash burn and the timeline for seeing returns on these new technologies.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending as speculation mounts around potential federal cannabis policy changes, specifically regarding rescheduling. Community chatter revolves around whether an executive order will materialize, with some anticipating a significant sector-wide surge while others remain cautiously optimistic due to past disappointments. The ETF's exposure to US cannabis companies positions it to potentially benefit from any regulatory easing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Firefly Neuroscience, Inc. (NASDAQ: AIFF)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Firefly Neuroscience, Inc. (NASDAQ: AIFF) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder...

Firefly Neuroscience rallied in its strongest session in more than a month on Tuesday after unveiling its new Clear Platform, a proprietary electroencephalogram (EEG) preprocessing technology built with Nvidia’s L40S GPU acceleration.The stock closed up 4.6% at $2.71 on Tuesday and added another 1.5% in after-hours trade.The medtech firm stated that the system achieves substantial processing speed gains of 60–80% while maintaining high signal quality, thereby enabling cleaner brainwave data for biomarker discovery and clinical research.&nbsp;Firefly stated that the platform could unlock new AI-driven insights to advance the diagnosis, treatment, and monitoring of neurological and psychiatric conditions.“Data quality is the foundation of clinical insight,” said Gil Issachar, Firefly’s Chief Technology Officer. “By combining our advanced preprocessing methods with Nvidia GPU acceleration, the Clear Platform represents the achievement of a key milestone along our path of building a foundation model of the human brain.”The launch comes months after&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/aiff-stock-soars-after-nvidia-connect-program-nod/ch5au23RuF">Firefly was accepted into the Nvidia Connect Program</a>, which provides participating companies with software development resources and technical training.CEO Greg Lipschitz said the rollout will play a central role in the company’s growth strategy, supporting efforts to discover and advance breakthrough brain biomarkers that can aid pharmaceutical R&amp;D, clinical trials, and patient care.Firefly develops AI-driven brain health tools and already holds FDA clearance for its Brain Network Analytics technology, which supports diagnosis and treatment monitoring for depression, dementia, anxiety, concussions, and ADHD.On Stocktwits, retail sentiment for Firefly was ‘extremely bullish’ amid an 11,700% surge in 24-hour message volume.One user described the stock as “a pound on the table” buy, calling it a potential multibagger in its early stages.<stembedurl>https://stocktwits.com/elgreg_2002/message/626646720</stembedurl>Another user predicted Firefly’s software could become the future of EEG diagnostics, noting that current brainwave readings are often noisy and time-consuming to interpret.&nbsp;With AI-driven clarity, they said, the company could cut delays in diagnosis and “be making a fortune.”<stembedurl>https://stocktwits.com/megamaven/message/626633235</stembedurl><a href="https://stocktwits.com/symbol/AIFF">Firefly Neuroscience’s stock</a> has risen 2.3% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Firefly Neuroscience’s stock has risen 2.3% so far in 2025. (Photo credit: Getty Images)

Firefly Neuroscience Stock Scores Biggest Gain In Weeks On Nvidia Brain Platform Boost: Retail Says ‘Pound On The Table’ Buy

The surge followed the debut of Firefly’s Clear EEG technology, which promises faster, cleaner brain data for biomarker discovery. 

Equity

This Hidden-Gem Stock Is Skyrocketing on Nvidia News. Should You Buy It Now?

Firefly Neuroscience’s stock has skyrocketed over 200% in five days after joining Nvidia’s Partner Connect Program.

Shares of Firefly Neuroscience Inc. surged more than 30% on Wednesday afternoon, reaching their highest levels in over nine months.&nbsp;The micro-cap medtech firm’s stock was experiencing the largest jump in retail following among health care stocks on Stocktwits, with trading volume nearly 10 times the daily average of 7.29 million shares.The rally followed Firefly’s announcement on Tuesday that it had been accepted into the Nvidia Connect program, which provides participating companies with software development resources and technical training.Firefly plans to leverage these tools to build a human brain foundation model using its FDA-cleared Brain Network Analytics (BNA) technology platform.&nbsp;Developed with artificial intelligence and machine learning, BNA aims to enhance doctors’ insights into brain function and improve diagnostic accuracy for patients with neurological and mental disorders.That announcement sent Firefly shares rocketing 170% higher on Tuesday, marking their best session ever.On Stocktwits, Firefly — currently valued at just $88.6 million — has drawn increasing attention.&nbsp;Its retail following has soared by nearly 70% over the past month, while message volume has exploded by more than 168,000%.&nbsp;A poll on the platform asking whether the stock’s squeeze had real momentum saw 62% of respondents voting “Yes, $20+ soon,” while 28% called it a “pump and dump.”<figure class="image"><img style="aspect-ratio:1290/644;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/AIFF_Stocktwits_Poll_On_Feb_12_0cf377b1b2.png" alt="AIFF Stocktwits Poll On Feb 12.png" width="1290" height="644"><figcaption>AIFF Stocktwits Poll On Feb 12</figcaption></figure>Short interest in Firefly has jumped from 2.6% at the start of the year to 26.7% by the end of January, according to Koyfin data.&nbsp;The company went public via a $45 million reverse merger with IT group WaveDancer last August, and shares have gained nearly 37% since then.For updates and corrections, email newsroom[at]stocktwits[dot]com.

On Stocktwits, Firefly — currently valued at just $88.6 million — has drawn increasing attention. | Image source: Getty Images

Firefly Neuroscience Leads Health Care Retail Follower Surge After Nvidia Connect Program Nod Sends Stock Soaring

The medtech firm plans to leverage these tools to build a human brain foundation model using its FDA-cleared Brain Network Analytics technology platform.

Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company, which engages in developing neuroscientific solutions for mental illnesses and neurological disorders. It offers Brain Network Analytics (BNA) platform, a software as a medical solution for the diagnostic and treatment methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD. The company was founded in 1979 and is headquartered in Kenmore, NY.

AIFF
Firefly Neuroscience Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest AIFF News

AIFFFirefly Neuroscience Inc.